Seattle Genetics, Inc. Announces Management Team Addition and Promotion to Support SGN-35 Commercialization Initiatives

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced the appointment of Vaughn B. Himes, Ph.D., as Executive Vice President, Technical Operations and the promotion of Morris Z. Rosenberg, D.Sc., to Executive Vice President, Process Sciences. In addition, the company has recognized Peter D. Senter, Ph.D., Vice President, Chemistry, as the company’s first Distinguished Fellow.

MORE ON THIS TOPIC